A majority of patients with Type 1 diabetes who were treated with dapagliflozin, a Type 2 diabetes medicine, had a significant decline in their blood sugar levels, according to a new study by a University at Buffalo researcher.
Five-year grant is a reflection of the recognition UB has received from the National Institutes of Health for the program’s outstanding record of cancer epidemiology training.
Children from unintended pregnancies tend to experience more depressive symptoms in early adulthood compared to children from intended pregnancies, however there’s little evidence of a causal relationship, according to a new UB study.
With the support of a new $1.58 million grant from the National Institutes of Health (NIH), University at Buffalo researchers aim to develop a targeted treatment to prevent communication between cancer cells.
University at Buffalo researchers have assembled a team of three antibiotics that, together, are capable of eradicating E. coli carrying mcr-1 and ndm-5 — genes that make the bacterium immune to last-resort antibiotics.
Four studies focused on improving our understanding of the human genome and microbiome were awarded funding through the third round of research pilots supported by the University at Buffalo’s Community of Excellence in Genome, Environment and Microbiome (GEM).